Xuemei Ou

1.4k total citations · 1 hit paper
34 papers, 944 citations indexed

About

Xuemei Ou is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Xuemei Ou has authored 34 papers receiving a total of 944 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 10 papers in Physiology and 7 papers in Molecular Biology. Recurrent topics in Xuemei Ou's work include Chronic Obstructive Pulmonary Disease (COPD) Research (13 papers), Asthma and respiratory diseases (5 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Xuemei Ou is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (13 papers), Asthma and respiratory diseases (5 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Xuemei Ou collaborates with scholars based in China, United States and Qatar. Xuemei Ou's co-authors include Qingmei Xu, Jinfeng Li, Martin Hauer‐Jensen, Junru Wang, Huaien Zheng, Yulin Feng, Ke Wang, Louis M. Fink, Fuqiang Wen and Andrew G. Geiser and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and American Journal Of Pathology.

In The Last Decade

Xuemei Ou

34 papers receiving 926 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The risk of falls among the aging population: A systematic review and meta-analysis

2022 149 citations Qingmei Xu, Xuemei Ou et al. Frontiers in Public Health profile →

Peers

Countries citing papers authored by Xuemei Ou

Since Specialization

Citations

This map shows the geographic impact of Xuemei Ou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuemei Ou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuemei Ou more than expected).

Fields of papers citing papers by Xuemei Ou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuemei Ou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuemei Ou. The network helps show where Xuemei Ou may publish in the future.

Co-authorship network of co-authors of Xuemei Ou

This figure shows the co-authorship network connecting the top 25 collaborators of Xuemei Ou. A scholar is included among the top collaborators of Xuemei Ou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuemei Ou. Xuemei Ou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Impact of Lung Cancer in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE) 2023 ·Journal of Clinical Medicine ·(unknown), (unknown), (unknown), Qinxue Li, Binmiao Liang, Xuemei Ou	1
2	The risk of falls among the aging population: A systematic review and meta-analysis breakdown → 2022 ·Frontiers in Public Health ·Qingmei Xu, Xuemei Ou, Jinfeng Li	149
3	Severe Influenza With Invasive Pulmonary Aspergillosis in Immunocompetent Hosts: A Retrospective Cohort Study 2021 ·Frontiers in Medicine ·(unknown), (unknown), (unknown), (unknown), Binmiao Liang, Xuemei Ou	12
4	Prediction of prognosis in chronic obstructive pulmonary disease patients with respiratory failure: A comparison of three nutritional assessment methods 2018 ·European Journal of Internal Medicine ·Ruiqi Chen, Xing Lu, Chao You, Xuemei Ou	23
5	HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue-Destructive Phenotype 2017 ·Cell Reports ·Nancy P. Y. Chung, Xuemei Ou, Korsa Khan, Jacqueline Salit, Robert J. Kaner, Ronald G. Crystal	12
6	Advanced Chronic Obstructive Pulmonary Disease 2015 ·Chinese Medical Journal ·Haixia Zhou, Xuemei Ou, Yongjiang Tang, Lan Wang, Yulin Feng	17
7	Validation of a Venous Thromboembolism Risk Assessment Model in Hospitalized Chinese Patients: A Case-Control Study 2013 ·Journal of Atherosclerosis and Thrombosis ·Haixia Zhou, Lan Wang, (unknown), Yongjiang Tang, Jing Yang, Bo Wang, (unknown), Binmiao Liang, Ke Wang, Xuemei Ou, Maoyun Wang, Yulin Feng, Qun Yi	29
8	Association of FAM13A polymorphisms with COPD and COPD-related phenotypes in Han Chinese 2013 ·European Respiratory Journal ·Bo Wang, (unknown), Jing Yang, Jun Xiao, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Xuemei Ou, Yulin Feng	3
9	Association of HHIP polymorphisms with COPD and COPD-related phenotypes in a Chinese Han population 2013 ·Gene ·Bo Wang, Haixia Zhou, Jing Yang, Jun Xiao, Binmiao Liang, Dengxue Li, Hong Zhou, Qingfei Zeng, Chunju Fang, (unknown), He Yu, Xuemei Ou, Yulin Feng	28
10	Association of IREB2 and CHRNA3/5 polymorphisms with COPD and COPD-related phenotypes in a Chinese Han population 2012 ·Journal of Human Genetics ·Haixia Zhou, Jing Yang, Dengxue Li, Jun Xiao, Bo Wang, Lan Wang, (unknown), (unknown), Xuemei Ou, Yulin Feng	31
11	Simvastatin attenuates experimental small airway remodelling in rats 2009 ·Respirology ·Xuemei Ou, Fuqiang Wen, Bruce D. Uhal, Yulin Feng, (unknown), Tao Wang, Ke Wang, Daishun Liu, Xun Wang, Lei Chen	31
12	Macrolides attenuate mucus hypersecretion in rat airways through inactivation of NF‐κB 2008 ·Respirology ·Xuemei Ou, (unknown), Fuqiang Wen, Ke Wang, Jie Yang, (unknown), Daishun Liu, Yanping Li	36
13	Increased expression of human calcium‐activated chloride channel 1 gene is correlated with mucus overproduction in Chinese asthmatic airway 2007 ·Cell Biology International ·Ke Wang, Fuqiang Wen, (unknown), Xuemei Ou, Dan Xu, Jie Yang, (unknown)	5
14	Decreased expression of human aquaporin-5 correlated with mucus overproduction in airways of chronic obstructive pulmonary disease 2007 ·Acta Pharmacologica Sinica ·Ke Wang, Yulin Feng, Fuqiang Wen, Xuerong Chen, Xuemei Ou, (unknown), Jie Yang, (unknown)	56
15	Sequential activation of protein kinase C δ and JNK is required for interferon-α-induced expression of IFIT4 2007 ·Cellular Signalling ·Xiangyang Huang, (unknown), Xuemei Ou, Dong Li, Zhongming Wang, (unknown), Yongtao Chen, (unknown), (unknown), Fuqiang Wen	7
16	Regulation of early and delayed radiation responses in rat small intestine by capsaicin-sensitive nerves 2006 ·International Journal of Radiation OncologyBiologyPhysics ·Junru Wang, Huaien Zheng, Ashwini Kulkarni, Xuemei Ou, Martin Hauer‐Jensen	29
17	Up-regulation and Activation of Proteinase-Activated Receptor 2 in Early and Delayed Radiation Injury in the Rat Intestine: Influence of Biological Activators of Proteinase-Activated Receptor 2 2003 ·Radiation Research ·Junru Wang, Huaien Zheng, Morley D. Hollenberg, (unknown), Xuemei Ou, Martin Hauer‐Jensen	27
18	Deficiency of Microvascular Thrombomodulin and Up-Regulation of Protease-Activated Receptor-1 in Irradiated Rat Intestine 2002 ·American Journal Of Pathology ·Junru Wang, Huaien Zheng, Xuemei Ou, Louis M. Fink, Martin Hauer‐Jensen	129
19	Regulation of the promoters for the human bone morphogenetic protein 2 and 4 genes 2000 ·Gene ·Leah M. Helvering, (unknown), Xuemei Ou, Andrew G. Geiser	83
20	Identification and Functional Characterization of the Murine Rac2 Gene Promoter 1999 ·DNA and Cell Biology ·Xuemei Ou, Jonathan Pollock, (unknown), Elisabeth Gharehbaghi-Schnell, David G. Skalnik	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact